Tilray Brands, Inc. (ETR:2HQ)
| Market Cap | 837.09M |
| Revenue (ttm) | 722.11M |
| Net Income (ttm) | -1.82B |
| Shares Out | n/a |
| EPS (ttm) | -17.98 |
| PE Ratio | n/a |
| Forward PE | 20.08 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,933 |
| Average Volume | 16,048 |
| Open | 6.99 |
| Previous Close | 7.16 |
| Day's Range | 6.57 - 7.11 |
| 52-Week Range | 2.80 - 19.88 |
| Beta | 2.12 |
| RSI | 28.00 |
| Earnings Date | Jan 8, 2026 |
About Tilray Brands
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the c... [Read more]
Full Company ProfileFinancial Performance
In 2025, Tilray Brands's revenue was $821.31 million, an increase of 4.10% compared to the previous year's $788.94 million. Losses were -$2.19 billion, 792.6% more than in 2024.
Financial numbers in USD Financial StatementsNews
Tilray Valuation Attractive With Strong Growth Overseas, Analyst Says
Tilray Brands Inc. (NASDAQ: TLRY) on Thursday reported quarterly earnings of one cent per share, which beat the Street estimate for a loss of 20 cents . Quarterly revenue came in at $217.51 million, ...
Marijuana industry taking fight against Wall Street blockades straight to Trump
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...
Tilray Brands (TLRY) Surges on Record Revenue Beat
Tilray Brands (TLRY) Surges on Record Revenue Beat
Why Tilray Brands Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Full story available on Benzinga.com
Tilray Brands Inc (TLRY) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth ...
Tilray Brands Inc (TLRY) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Market Challenges
Q2 2026 Tilray Brands Inc Earnings Call Transcript
Q2 2026 Tilray Brands Inc Earnings Call Transcript
Tilray Brands (TLRY) Reports Record Q2 Revenue, Beats Expectations
Tilray Brands (TLRY) Reports Record Q2 Revenue, Beats Expectations
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Tilray Brands, Inc. Q2 Loss Decreases
(RTTNews) - Tilray Brands, Inc. (TLRY) reported Loss for second quarter of -$44.93 million
Why Tilray Brands Stock Is Rising in After-Hours Trading
Tilray had good things to say about its recent quarter -- and investors were listening.
Tilray Brands (TLRY) Reports Record Revenue, Shares Surge
Tilray Brands (TLRY) Reports Record Revenue, Shares Surge
Stocks making the biggest moves after hours: General Motors, Intel, Tilray Brands & more
These are the stocks posting the largest moves in extended trading.
Tilray Stock Fires Up After Record Q2 Earnings: Here's Why
Tilray Brands, Inc.. (NASDAQ: TLRY) shares climbed in Thursday's extended trading after the company released its second-quarter earnings report, beating expectations on the top and bottom lines. Here...
Tilray Stock Fires Up After Record Q2 Earnings: Here's Why
Tilray Brands, Inc.. (NASDAQ: TLRY) shares climbed in Thursday's extended trading after the company released its second-quarter earnings report, beating expectations on the top and bottom lines.
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock...
Tilray Brands (TLRY) Faces Earnings Headwinds
Tilray Brands (TLRY) Faces Earnings Headwinds
Tilray Brands Q2 preview: Bottom line weakness to persist but reclassification offers hope
Tilray (TLRY) Q2 earnings preview: EPS loss expected, flat revenue, margin pressures and U.S. cannabis rescheduling catalysts.
A Look Ahead: Tilray Brands's Earnings Forecast
Tilray Brands (NASDAQ: TLRY) is gearing up to announce its quarterly earnings on Thursday, 2026-01-08. Here's a quick overview of what investors should know before the release. Analysts are estimatin...
Top Wall Street Forecasters Revamp Tilray Brands Expectations Ahead Of Q2 Earnings
Tilray Brands, Inc. (NASDAQ: TLRY) will release earnings results for its second quarter after the closing bell on Thursday, Jan. 8, 2025. Analysts expect the Leamington, Canada-based company to repor...
Top Wall Street Forecasters Revamp Tilray Brands Expectations Ahead Of Q2 Earnings
Tilray Brands, Inc. (NASDAQ: TLRY) will release earnings results for its second quarter after the closing bell on Thursday, Jan. 8, 2025.
Tilray Q2: High Hopes or Harsh Reality?
As Canadian cannabis king Tilray Brands, Inc. (NASDAQ: TLRY) prepares to report its fiscal Q2 2026 results on Thursday, the company stands at a crossroads. TLRY stock is moving. See the chart and pri...
Tilray Q2: High Hopes or Harsh Reality?
As Canadian cannabis king Tilray Brands, Inc. (NASDAQ: TLRY) prepares to report its fiscal Q2 2026 results on Thursday, the company stands at a crossroads.
Tilray Brands Readies for Q2 Earnings: Here's What You Should Know
TLRY's faces margin pressure in cannabis and beverages, but management sees a beverage turnaround and wellness strength cushioning quarterly results.
Best Canadian Cannabis Stocks to Watch Entering 2026
The cannabis industry continues to evolve as investors look toward 2026 with renewed optimism. Canadian cannabis companies remain at the center of global expansion. They benefit from strong medical pr...
Tilray stock forms a risky pattern: Jan. 8 will be key
Tilray stock price has been highly volatile in the past few months as investors focused on Donald Trump's cannabis reclassification efforts and its implications. It surged from $3.59 in June to a high...